Justin Leong - Nov 16, 2021 Form 4/A - Amendment Insider Report for RESMED INC (RMD)

Role
President, Asia Latin America
Signature
Justin Leong, President Asia and Latin America
Stock symbol
RMD
Transactions as of
Nov 16, 2021
Transactions value $
$2,188,747
Form type
4/A - Amendment
Date filed
1/4/2022, 04:42 PM
Date Of Original Report
Nov 18, 2021
Previous filing
Aug 20, 2021
Next filing
Nov 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMD ReMed Common Stock Award $2.33M +9.16K +22.51% $254.81 49.9K Nov 16, 2021 Direct F1
transaction RMD ReMed Common Stock Tax liability -$146K -562 -1.13% $259.47 49.3K Dec 31, 2021 Direct F2
transaction RMD ReMed Common Stock Award $0 +638 +1.29% $0.00 49.9K Nov 18, 2021 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted stock units granted on November 14, 2018. The shares were earned on November 16, 2021, when the compensation committee certified that the performance metrics were met
F2 Amended to report the disposition to issuer for tax withholding on vesting of performance-based Restricted Stock Units granted on 11/14/2018, 11/21/2019 and 11/19/2020.
F3 Represents performance-based restricted stock units granted on November 19, 2020. The shares were earned on November 18, 2021, when the compensation committee certified that the performance metrics were met for this portion of the grant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date.